Pharmaceutical-Induced Dyskinesia: A Case Study of Thoracotomy Treated with Amantadine

Mojtaba  Mojtahedzadeh; Atabak  Najafi; Farahnaz  Hosseinzadeh; Fatemeh  Saghafi

doi:10.18502/crcp.v9i4.17983

Mojtaba Mojtahedzadeh Department of Clinical Pharmacy, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Atabak Najafi Department of Anesthesiology and Critical Care Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Farahnaz Hosseinzadeh Pharmaceutical Sciences Research Center, School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Fatemeh Saghafi Department of Clinical Pharmacy, School of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

DOI: https://doi.org/10.18502/crcp.v9i4.17983

Keywords: Dyskinesia; Amantadine; Adverse effect; Thoracotomy

Abstract

Dyskinesia, marked by involuntary and irregular movements, can result fromvarious pharmaceutical agents. The case presented features a patient undergoingthoracotomy, experiencing dyskinesia, likely attributed to antipsychotics, antiemetics,and antibiotics, and subsequently treated with amantadine.